乙型肝炎肝硬化和肝癌患者血清铁蛋白检测的意义

doi:10.3969/j.issn.1672-5069.2016.06.029

Abstract

Cheng Dan，Shao Zhilin，Wu Liang，et al.. Serum ferritin in patients with chronic hepatits B liver cirrhosis and primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 736-737.

[1] 沈永青，刘贝，石振华，等．铁过载与癌症的发生．中国肿瘤临床，2012，50（21）:1675．
[2] Detivaud L，Nemeth E，Boudjema K，et al. Hepcidin levels in humans are correlated with hepatic iron stores，hemoglobin levels，and hepatic function. Blood，2005，106:746-748.
[3] Asare GA，Paterson AC，Kew MC，et al. Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron. Pathology，2006，208:82-90.
[4] Alkhateeb AA，Connor JR. The siginificance of ferritin in cancer:anti-oxidation，inflammation and tumorigenesis. Biochem Biophys Acta Rev Cancer，2013，1836（2）:245-254.
[5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）：81-89.
[6] 中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分期标准. 中华肝脏病杂志，2001，9：324.
[7] 周晶，王莉娜. 血清SF、CEA和CRP联合检测诊断非小细胞肺癌的价值. 海南医学，2015，26（20）:3015-3017.
[8] Sebastiani G，Tempesta D，Alberti A．Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus．J Viral Hepat，2012，19: e170-e176．
[9] 冯红萍. 甲胎蛋白与血清铁蛋白联合检测在慢性乙型重症肝炎中的临床意义. 现代诊断与治疗，2007，18:232-233．
[10] 武抗抗，吴超. 血清铁蛋白水平在慢性病毒性肝炎中检测意义的研究进展. 中华临床医师杂志电子版，2013，7（12）:5568-5570．
[11] 范公忍，周一鸣，韩聚强，等．血清铁蛋白及转铁蛋白联合检测在肝脏疾病中的应用．检验医学与临床，2013，16（10）:2076-2077.
[12] 李坤，沈天白，李莹. 慢性乙型肝炎和乙型肝炎肝硬化患者血清铁蛋白的变化. 实用肝脏病杂志，2015，18（6）:620-623.
[13] 赵晶晶，李嘉，刘洁，等. 肝病患者血清铁蛋白水平与肝脏炎症程度及肝病类型的关系. 山东医药，2015，55（9）:21-23.
[14] Gopakumar G，Belanzoni P，Baerends EJ. Hydroxylation catalysis by mononuclear and dinuclear iron oxocatalysts:a methane monooxygenase model system versus the Fenton reagent Fe（IV）O（H2O）5（2+）. Inorg Chem，2012，51:63-75.
[15] 江远，张玲，钟肖英，等. 铁沉积对大鼠肝纤维化影响的机制研究. 实用肝脏病杂志，2015，18（2）:173-177.
[16] Cujic D，Golubovic S，Bojic-Trbojevic Z，et al．Differential diagnosis of liver diseases using serum biomarkers．J Buon，2010，15（1）:141-146.
[17] 程玉萍. 血清铁蛋白检查在临床应用的研究进展.山西医药杂志，2013，42（6）:639-640.

Serum ferritin in patients with chronic hepatits B liver cirrhosis and primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[5]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[6]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[7]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[8]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[9]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[12]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[13]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[14]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[15]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.